Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer (Q63444335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

adverse prognostic factor

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Luigi Tornillo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Alessandro Lugli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Inti Zlobec

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ursula Günthert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Parham Minoo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Luigi Terracciano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jeremy R Jass

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

9 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1302-1309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16763611%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.3800648

29 January 2020

exact match

0 references

cites work

The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Signaling properties of hyaluronan receptors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Development of anticancer drugs targeting the MAP kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Requirement of Ras-GTP-Raf Complexes for Activation of Raf-1 by Protein Kinase C

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

The hyaluronan receptor RHAMM regulates extracellular-regulated kinase

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Tissue microarrays in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Characterisation of tumour-associated antigens in colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal–regulated kinase, and phosphorylated AKT in colorectal cancer—A tissue microarray–based approach?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Prognostic value of tumor "budding" in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Long-term results of curative resection of "minimally invasive" colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Indicators for treatment strategies of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Colorectal cancer with and without microsatellite instability involves different genes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Alternative genetic pathways in colorectal carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Beta-catenin--a linchpin in colorectal carcinogenesis?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021

Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800648

7 January 2021